A small human study found that one session of HIIT or resistance training boosted anti-cancer proteins in the blood of breast-cancer survivors and slowed lab-grown cancer cells. It’s not a cure—but it’s a powerful reason to move with purpose.
New research on “superagers” shows that some people in their 80s keep memory on par with folks in their 50s—often with thicker, more resilient brain regions and powerful social lives. Here’s what sets them apart and three habits you can start this week.
A new analysis of Maria Branyas Morera—the world’s oldest person until she died at 117—suggests extraordinary longevity isn’t one magic gene. It’s a messy blend of lucky genetics, a resilient immune system, a youthful gut microbiome (hello, yogurt), and steady, low-drama habits. But here’s the catch: it’s still one person. Treat the findings as clues, not commandments.
Cycling shouldn’t come with nagging hip pain, stiff knees, or a sore back.
Whether you ride the Swamp Rabbit Trail or train for long weekend rides, a few minutes of targeted movement can help you stay strong, mobile, and pain-free.
A new study points to a “bone switch” (GPR133): turning it on with a compound called AP503 made mouse bones stronger and even reversed osteoporosis-like loss. Early, preclinical—but it hints at treatments that rebuild bone, not just slow decline.
Russia says it’ll launch a **personalized mRNA cancer vaccine** in 2025—potentially free to patients. Intriguing, but it’s still light on peer-reviewed human data, so file under **watch-list**, not proven therapy. ([drvaccines.com][1])
[1]: https://www.drvaccines.com/blog/russias-new-mrna-cancer-vaccine-launching-in-2025-a-breakthrough-in-cancer-treatment?utm_source=chatgpt.com “Russia’s New mRNA Cancer Vaccine Launching in 2025”
A “four-in-one” obesity drug that targets GLP-1, GIP, glucagon, and PYY aims to push weight loss toward \~30% while reducing nausea and muscle loss; it’s still preclinical (no human data yet), but it points beyond today’s GLP-1s. ([Yahoo][1])
[1]: https://www.yahoo.com/news/articles/next-ozempic-aims-deliver-30-110036301.html?utm_source=chatgpt.com “‘Next Ozempic’ aims to deliver 30% weight loss with fewer side …”
Exact Sciences’ new **CancerGuard** is a single-draw blood test that analyzes multiple biomarker classes to flag signals from **50+ cancers**. It’s a **\$689** U.S. **lab-developed test** meant to **complement** existing screenings—not replace them. ([Exact Sciences][1])
[1]: https://www.exactsciences.com/newsroom/press-releases/exact-sciences-launches-cancerguard-first-of-its-kind-multi-cancer-early-detection-blood-test “Exact Sciences Launches Cancerguard, First-of-Its-Kind Multi-Cancer Early Detection Blood Test | Exact Sciences”
Two fresh bites on longevity: one thread champions a “longevity diet” as a legit way to extend life, the other debates whether stacking lots of hacks beats keeping it simple. Takeaway—focus on consistent, evidence-leaning basics before chasing synergy. Want a quick start? Use our **AI Prompt of the Month** to auto-build a one-page daily plan (movement, simple strength, sleep, meals) tailored to you.
– Harvard’s David Sinclair predicts rejuvenation trials by 2027. – Surge in off-label Rapamycin usage for lifespan extension. – AI reengineers nobel-winning proteins to reverse
